Skip to main content

Advertisement

SpringerLink
Log in

Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B

  • Letters to the editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

An Erratum to this article was published on 01 September 2006

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. P Marcellin TT Chang SG Lim MJ Tong W Sievert ML Shiffman et al. (2003) ArticleTitleAdefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B N Engl J Med 348 808–16 Occurrence Handle10.1056/NEJMoa020681 Occurrence Handle1:CAS:528:DC%2BD3sXhsFKisrc%3D Occurrence Handle12606735

    Article  CAS  PubMed  Google Scholar 

  2. SJ Hadziyannis NC Tassopoulos EJ Heathcote TT Chang G Kitis P Rizzetto et al. (2003) ArticleTitleAdefovir dipivoxil for the treatment of hepatitis B e antigen–negative chronic hepatitis B N Engl J Med 348 800–7 Occurrence Handle10.1056/NEJMoa021812 Occurrence Handle1:CAS:528:DC%2BD3sXhsFKju7w%3D Occurrence Handle12606734

    Article  CAS  PubMed  Google Scholar 

  3. R Perrillo E Schiff E Yoshida A Statler K Hirsch T Wright et al. (2000) ArticleTitleAdefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants Hepatology 32 129–34 Occurrence Handle10.1053/jhep.2000.8626 Occurrence Handle1:CAS:528:DC%2BD3cXltFWgs7c%3D Occurrence Handle10869300

    Article  CAS  PubMed  Google Scholar 

  4. MG Peters HH Hann P Martin EJ Heathcote P Buggisch R Rubin et al. (2004) ArticleTitleAdefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B Gastroenterology 126 91–101 Occurrence Handle10.1053/j.gastro.2003.10.051 Occurrence Handle1:CAS:528:DC%2BD2cXhtFGntLo%3D Occurrence Handle14699491

    Article  CAS  PubMed  Google Scholar 

  5. JJY Sung JY Lai S Zeuzem WC Chow E Heathcote R Perrillo et al. (2003) ArticleTitleA randomized double-blind phase II study of LAM compared to LAM plus ADV for treatment naïve patients with chronic hepatitis B (CHB): week 52 analysis (abstract) J Hepatol 38 IssueIDsuppl 2 25 Occurrence Handle10.1016/S0168-8278(03)80485-3

    Article  Google Scholar 

  6. SK Fung P Andreone SH Han KR Reddy A Regev EB Keeffe et al. (2005) ArticleTitleAdefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation J Hepatol 43 937–43 Occurrence Handle10.1016/j.jhep.2005.05.037 Occurrence Handle1:CAS:528:DC%2BD2MXht1egsrnP Occurrence Handle16168522

    Article  CAS  PubMed  Google Scholar 

  7. SJ Hadziyannis NC Tassopoulos TT Chang J Heathcote G Kitis M Rizzetto et al. (2004) ArticleTitleThree year study of adefovir dipivoxil demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES) (abstract) J Hepatol 40 IssueIDsuppl 1 17 Occurrence Handle10.1016/S0168-8278(04)90046-3

    Article  Google Scholar 

  8. SJ Hadziyannis NC Tassopoulos EJ Heathcote TT Chang G Kitis M Rizzetto et al. (2005) ArticleTitleLong-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B N Engl J Med 352 2673–81 Occurrence Handle10.1056/NEJMoa042957 Occurrence Handle1:CAS:528:DC%2BD2MXls1Sksbc%3D Occurrence Handle15987916

    Article  CAS  PubMed  Google Scholar 

  9. MN Brunelle AC Jacquard C Pichoud D Durantel S Carrouee-Durantewl JP Villeneuve et al. (2005) ArticleTitleSusceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir Hepatology 41 1391–8 Occurrence Handle10.1002/hep.20723 Occurrence Handle1:CAS:528:DC%2BD2MXlvVSmsrg%3D Occurrence Handle15915463

    Article  CAS  PubMed  Google Scholar 

  10. P Angus R Vaughan S Xiong H Yang W Delaney C Gibbs et al. (2003) ArticleTitleResistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase Gastroenterology 125 292–7 Occurrence Handle10.1016/S0016-5085(03)00939-9 Occurrence Handle12891527

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, 3-39-15 Showa, Maebashi, 371-8511, Japan

    Ken Sato, Hitoshi Takagi, Satoru Kakizaki, Naondo Sohara & Masatomo Mori

Authors
  1. Ken Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hitoshi Takagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Satoru Kakizaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naondo Sohara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masatomo Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

An erratum to this article is available athttp://dx.doi.org/10.1007/s00535-006-1956-1.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sato, K., Takagi, H., Kakizaki, S. et al. Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B. J Gastroenterol 41, 283–285 (2006). https://doi.org/10.1007/s00535-006-1770-9

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-006-1770-9

Keywords

Search

Navigation